Quality of Life, Adverse Events, and Reintervention Outcomes after Laparoscopic Radiofrequency Ablation for Symptomatic Uterine Fibroids: A Meta-Analysis
- PMID: 30253997
- DOI: 10.1016/j.jmig.2018.09.772
Quality of Life, Adverse Events, and Reintervention Outcomes after Laparoscopic Radiofrequency Ablation for Symptomatic Uterine Fibroids: A Meta-Analysis
Abstract
In this review, we assessed the short-term (3 and 6 months) and long-term (12, 24, and 36 months) symptom relief and quality of life improvement, procedure-related adverse event rate, reintervention rate, and days missed from work after laparoscopic radiofrequency ablation. Using MeSH keywords "uterine fibroid" and "ablation technique," a systematic search was performed in PubMed, Ovid, Embase, Cochrane Library, and Clinicaltrials.gov. Studies consisting of uterine fibroid symptoms and quality of life scores were considered eligible. Both comparative and noncomparative studies were included. Using a random-effects model, a meta-analysis was performed. Eight studies with a total of 581 patients were finally included in our review. Based on validated questionnaires, quality of life improved significantly until 36 months after laparoscopic radiofrequency ablation therapy, with a maximum improvement (Health-Related Quality of Life [HRQL] questionnaire score of +41.64 [95% confidence interval (CI), 38.94-44.34] and a transformed Symptom Severity Score [tSSS] of -39.37 [95% CI, 34.70-44.04]) at 12 months after laparoscopic radiofrequency ablation. All subscales of quality of life improved significantly, and most of the changes remained stable in long-term follow-up. The overall reintervention rate was 4.39% (95% CI, 1.60%-8.45%), and the median uterine volume reduction was 69.17 cm³ (95% CI, 35.87-102.46 cm³).The overall procedure-related adverse events rate was 1.78% (95% CI, 0.62%-3.53%), and patients missed an average of 4.35 days (95% CI, 2.55-6.15 days) of work. In conclusion, laparoscopic radiofrequency ablation therapy is an efficacious way to treat small-sized and nonpedunculated symptomatic uterine fibroids, providing stable long-term symptom relief and quality of life improvement with a low risk of adverse events and reintervention and just a few days of missed work.
Keywords: Laparoscopic radiofrequency ablation; Meta-analysis; Quality of life; Symptomatic uterine fibroid.
Copyright © 2018 AAGL. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Uterine Artery Embolization Compared with High-intensity Focused Ultrasound Ablation for the Treatment of Symptomatic Uterine Myomas: A Systematic Review and Meta-analysis.J Minim Invasive Gynecol. 2021 Feb;28(2):218-227. doi: 10.1016/j.jmig.2020.11.004. Epub 2020 Nov 14. J Minim Invasive Gynecol. 2021. PMID: 33197612
-
Laparoscopic ultrasound-guided radiofrequency volumetric thermal ablation of symptomatic uterine leiomyomas: feasibility study using the Halt 2000 Ablation System.J Minim Invasive Gynecol. 2011 May-Jun;18(3):364-71. doi: 10.1016/j.jmig.2011.02.006. J Minim Invasive Gynecol. 2011. PMID: 21545960 Clinical Trial.
-
Radiofrequency Ablation for the Treatment of Uterine Fibroids: A Systematic Review and Meta-Analysis by the AAGL Practice Committee.J Minim Invasive Gynecol. 2025 Jan;32(1):74-91. doi: 10.1016/j.jmig.2024.09.011. Epub 2024 Sep 12. J Minim Invasive Gynecol. 2025. PMID: 39277104
-
Laparoscopic Radiofrequency Ablation of Uterine Leiomyomas: Clinical Outcomes during Early Adoption into Surgical Practice.J Minim Invasive Gynecol. 2020 May-Jun;27(4):915-925. doi: 10.1016/j.jmig.2019.07.025. Epub 2019 Jul 31. J Minim Invasive Gynecol. 2020. PMID: 31376584 Clinical Trial.
-
[Laparoscopic ultrasound-guided radiofrequency ablation of uterine fibroid: A retrospective study].Gynecol Obstet Fertil Senol. 2024 Sep;52(9):495-504. doi: 10.1016/j.gofs.2024.04.001. Epub 2024 Apr 9. Gynecol Obstet Fertil Senol. 2024. PMID: 38604536 French.
Cited by
-
Delayed expulsion of a large fibroid after transcervical radiofrequency ablation: A case report.Radiol Case Rep. 2022 Dec 18;18(3):779-783. doi: 10.1016/j.radcr.2022.11.063. eCollection 2023 Mar. Radiol Case Rep. 2022. PMID: 36589487 Free PMC article.
-
Uterine Leiomyoma Journey With Acessa ProVu System Using General Anesthesia Under Laparoscopic Ultrasound Guidance: A Case Report.Cureus. 2024 Feb 11;16(2):e54006. doi: 10.7759/cureus.54006. eCollection 2024 Feb. Cureus. 2024. PMID: 38476789 Free PMC article.
-
Durable Improvement in Generic and Fibroid-Specific Quality of Life in Women Treated with Transcervical Fibroid Ablation with the Sonata System After Three Years.J Gynecol Surg. 2022 Apr 1;38(2):143-147. doi: 10.1089/gyn.2021.0073. Epub 2022 Apr 1. J Gynecol Surg. 2022. PMID: 35497488 Free PMC article.
-
Combined procedure of the transcervical radiofrequency ablation (TRFA) system and surgical hysteroscopy. Increased risk or safe procedure?Wideochir Inne Tech Maloinwazyjne. 2022 Jun;17(2):380-384. doi: 10.5114/wiitm.2022.113565. Epub 2022 Feb 17. Wideochir Inne Tech Maloinwazyjne. 2022. PMID: 35707331 Free PMC article.
-
Image-guided cryoablation for uterine diseases: a systematic review.Quant Imaging Med Surg. 2025 Aug 1;15(8):7572-7584. doi: 10.21037/qims-2024-2816. Epub 2025 Jul 29. Quant Imaging Med Surg. 2025. PMID: 40785873 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
